연구

연구업적

최근 5년 연구업적 현황
연도 2025년 2024년 2023년 2022년 2021년
SCI 논문
발표편수
책임 196편 179편 173편 163편 184편
공동 132편 147편 120편 115편 136편
합계 328편 326편 293편 278편 320편
3055. The role of local treatment including pancreatectomy for pancreatic ductal adenocarcinoma patients with isolated synchronous liver metastasis: Propensity score-matched analyses.
Yun WG, Han Y, Lee M, Cho YJ, Jung HS, Thomas AS, Kluger MD, Kwon W, Jang JY.
J Hepatobiliary Pancreat Sci . 2023 Aug;30(8):1036-1045. Link
3054. Role of neoadjuvant treatment in resectable pancreatic cancer according to vessel invasion and increase of CA19-9 levels.
Kim HS, Lee M, Han Y, Kang JS, Kang YH, Sohn HJ, Kwon W, Lee DH, Jang JY.
J Hepatobiliary Pancreat Sci . 2023 Jul;30(7):924-934. Link
3053. Oncologic safety of robotic extended cholecystectomy for gallbladder cancer.
Cho, Y. J., Yun, W. G., Jung, H. S., Lee, M., Han, Y., Kwon, W., & Jang, J. Y.
Surgical Endoscopy (2023) 37:9089–9097 Link
3052. Efficacy of local treatment for isolated liver metastasis after pancreatectomy in pancreatic ductal adenocarcinoma: A propensity score-matched analysis.
Yun, W. G., Han, Y., Lee, M., Cho, Y. J., Jung, H. S., Kwon, W., & Jang, J. Y.
Journal of hepato-biliary-pancreatic sciences, 10.1002/jhbp.1352. Link
3051. Incidence of bactibilia and related factors in patients who undergo cholecystectomy.
Moon DK, Kang JS, Byun Y, Choi YJ, Lee HW, Jang JY, Lim CS.
Ann Surg Treat Res. 2023 Jan;104(1):10-17. Link
3050. Development of Spleen Targeting H2S Donor Loaded Liposome for the Effective Systemic Immunomodulation and Treatment of Inflammatory Bowel Disease
Chiwoo Oh 1, Wooseung Lee 1, Jeongbin Park 2, Jinyeong Choi 1, Somin Lee 2, Shengjun Li 2, Han Na Jung 1, Jeong-Seob Lee 1, Jee-Eun Hwang 2, Jiwoo Park 2, MinKyu Kim 1, Seungki Baek 1, Hyung-Jun Im 1 2 3 4
ACS Nano . 2023 Mar 14;17(5):4327-4345. Link
3049. In vitro magnetic hyperthermia properties of angle-shaped superparamagnetic iron oxide nanoparticles synthesized by a bromide-assisted polyol method
Hoonsub Kim 1, Pyung Won Im 2, Chaedong Lee 1, Hwichan Hong 1, Wooseung Lee 1, Changhyuk Koo 1, Sang Yoon Park 3, Hyung-Jun Im 1 2 4, Sun Ha Paek 2 4 5, Yuanzhe Piao 1 3
RSC Adv . 2023 Jan 19;13(5):2803-2810. Link
3048. 18F-FDG PET/CT in the Management of Osteosarcoma
Chiwoo Oh 1, Michael W Bishop 2, Steve Y Cho 3, Hyung-Jun Im 4 5 6, Barry L Shulkin 7
J Nucl Med . 2023 Jun;64(6):842-851. Link
3047. Injectable biocompatible nanocomposites of Prussian blue nanoparticles and bacterial cellulose as a safe and effective photothermal cancer therapy
Hwichan Hong # 1, MinKyu Kim # 1, Wooseung Lee 1, Miyeon Jeon 1, Chaedong Lee 1, Hoonsub Kim 1, Hyung-Jun Im 2 3 4 5 6, Yuanzhe Piao 7 8 9
J Nanobiotechnology . 2023 Oct 5;21(1):365. Link
3046. HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results
Jeongmin Seo,, Jiwon Koh, Dae-Won Lee, Jinyong Kim, Han Suk Ryu, Kyung-Hun Lee, Tae-Yong Kim, Seock-Ah Im
Breast Cancer Res 2023 Dec 14;25(1):154. Link